Aktive farmaceutiske ingredienser
Gestagen og østrogen | |||
produktnavn | Specifikation | godkendt | CAS-nr. |
Progesteron | CP/EP/USP | CEP/EU-GMP/FDA | 57-83-0 |
Medroxyprogesteronacetat | CP/EP/USP | DMF/GMP | 71-58-9 |
Megestrolacetat | CP/EP/USP | DMF under Arkiv | 595-33-5 |
Mifepriston | CP/IP | DMF/GMP | 84371-65-3 |
Cyproteronacetat | CP/EP | CEP/TGA/GMP | 427-51-0 |
Levonorgestrel | CP/EP/USP | DMF/GMP/CEpin-proces | 797-63-7 |
Drospirenon | EP/USP | DMF under Arkiv | 67392-87-4 |
Gestodene | CP/EP | DMF/GMP | 60282-87-3 |
Østradiol | CP/EP/USP | DMF | 50-28-2 |
Estriol | CP/EP/USP | Under R&D | 50-27-1 |
Ethinylestradiol | CP/EP/USP | DMF/GMP | 57-63-6 |
Østradiol Valerat | CP | DMF under Arkiv | 979-32-8 |
Tibolone | CP/EP | DMF | 5630-53-5 |
Dienogest | EP | DMF under Arkiv | 65928-58-7 |
Fulvestrant | EP/USP | Under R&D | 129453-61-8 |
androgen | |||
produktnavn | Specifikation | godkendt | CAS-nr. |
Finasteride | CP/EP/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
Dutasterid | EP/USP | CEP/DMF | 164656-23-9 |
Abirateronacetat | CP/USP | DMF | 154229-18-2 |
Testosteron | CP/EP/USP | DMF/CEP i gang | 58-22-0 |
Testosteron undecanoat | CP | DMF under Arkiv | 5949-44-0 |
Testosteron Cypionate | USP | DMF under Arkiv | 58-20-8 |
DHEA (prasteron) | FP/In-house | DMF/WC/Kosher | 53-43-0 |
Kortikalt hormon | |||
produktnavn | Specifikation | godkendt | CAS-nr. |
Budesonid | CP/EP/USP | CEP/FDA/GMP | 51333-22-3 |
Desonid | USP | DMF | 638-94-8 |
Eplerenon | EP | CEP/FDA | 107724-20-9 |
Methylprednisolon | CP/EP/USP | DMF/WC | 83-43-2 |
Methylprednisolon Hemisuccinat | CP/EP/USP | DMF/WC | 2921-57-5 |
Fluticasonpropionat | CP/EP/USP | DMF | 80474-14-2 |
Flutikasonfuroat | In-house | Under R&D | 397864-44-7 |
Mometasonfuroat | CP/EP/USP | Under R&D | 83919-23-7 |
Andre | |||
produktnavn | Specifikation | godkendt | CAS-nr. |
Oxcarbazepin | CP/EP/USP | CEP/DMF/GMP | 28721-07-5 |
Eslicarbazepinacetat | In-house | DMF under Arkiv | 236395-14-5 |
Ganciclovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
ValganciclovirHydrochlorid | USP | DMF under Arkiv | 175865-59-5 |
Oseltamivir fosfat | CP/EP/USP | DMF | 204255-11-8 |
Nintedanib Esylate | In-house | DMF | 656247-18-6 |
Revefenacin | In-house | DMF i gang | 864750-70-9 |
Mirabegron | In-house | DMF i gang | 223673-61-8 |
Cariprazin hydrochlorid | In-house | DMF i gang | 1083076-69-0 |
Lasmiditansuccinat | In-house | DMF i gang | 439239-92-6 |
Luliconazol | In-house | DMF i gang | 187164-19-8 |
produktnavn | Specifikation | godkendt | CAS-nr. |
16α-Hydroxyprednisolon | Min 99,0 % | DMF | 13951-70-7 |
16α-Hydroxyprednisolonacetat | Min 98,0 % | DMF | 86401-80-1 |
21-Acetoxy-11β-hydroxypregna-1,4,16-trien-3,20-dion | Min 98,0 % | TP | 3044-42-6 |
DHEA (prasterone) | Min 99,0 % | DMF/WC | 53-43-0 |
DHEA-acetat (prasteronacetat) | Min 99,0 % | DMF | 853-23-6 |
Epiandrosteron | Min 99,0 % | TP | 481-29-8 |
Abiraterone | I huset | DMF | 154229-19-3 |
Triacetyl-ganciclovir | Min. 98,5 % | TP | 86357-14-4 |
Mono-acetylganciclovir | Min. 97 % | TP | 194254-40-0 |
16-Dehydropregnenolonacetat ï¼16-DPAï¼ | Min 99,0 % | TP | 979-02-2 |
Pregnenolonacetat | Min 98,0 % | TP/ Kosher | 1778-02-5 |
Pregnenolon | Min 99,0 % | TP/Kosher | 145-13-1 |
3-Oxo-4-androsten-17β-carboxylsyre | Min 99,0 % | TP | 302-97-6 |
4-aza-5α-androstan-3-oxo-17β-carboxylsyre | Min 98,0 % | DMF | 103335-55-3 |
4-aza-5α-androstan-1-en-3-oxo-17β-carboxylsyre | Min 98,0 % | DMF | 104239-97-6 |
N-tert-butyl-3-oxo-4-aza-5α-androst-17β-carboxamid | Min 98,0 % | DMF | 98319-24-5 |
6-chlor-1α-chlormethyl-3,20-dioxo-pregna-4,6-dien-17α-acetoxy | Min 98,0 % | DMF | 17183-98-1 |
Estron | USP36 | TP | 53-16-7 |
Flumethason | Min 98,0 % | TP | 2135-17-3 |